Business
Holding(s) in Company
The Capital Group Companies, Inc. has reduced its voting rights in AstraZeneca PLC to 4.973499%, holding 77,125,348 voting rights, down from a previous holding of 5.017815%. This change, which occurred on December 2, 2025, involved the acquisition or disposal of voting rights, with no financial instruments contributing to the total holding. The notification was made on December 3, 2025, and the shares are held indirectly through various investment management subsidiaries. Disclaimer*
About this update from Astrazeneca Plc
[{"type":"text","content":"\n\nTR-1: Standard form for notification of major holdings\n\n1. Issuer Details\n\n\n\nISIN\n\n\nGB0009895292\n\n\nIssuer Name\n\n\nASTRAZENECA PLC\n\n\nUK or Non-UK Issuer\n\n\nUK\n\n\n\n2. Reason for Notification\n\n\nAn acquisition or disposal of voting rights\n\n\n3. Details of person subject to the notification obligation\n\n\n\nName\n\n\nThe Capital Group Companies, Inc.\n\n\nCity of registered office (if applicable)\n\n\nLos Angeles\n\n\nCountry of registered office (if applicable)\n\n\nUSA\n\n\n\n4. Details of the shareholder\n\n\n\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\n\n\n \n\n\nCity of registered office (if applicable)\n\n\n \n\n\nCountry of registered office (if applicable)\n\n\n \n\n\n\n5. Date on which the threshold was crossed or reached\n\n\n02-Dec-2025\n\n\n6. Date on which Issuer notified\n\n\n03-Dec-2025\n\n\n7. Total positions of person(s) subject to the notification obligation\n\n\n\n\n\n\n\n\n% of voting rights attached to shares (total of 8.A)\n\n\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\n\n\nTotal of both in % (8.A + 8.B)\n\n\nTotal number of voting rights held in issuer\n\n\n\n\nResulting situation on the date on which threshold was crossed or reached\n\n\n4.973499\n\n\n0.000000\n\n\n4.973499\n\n\n77125348\n\n\n\n\nPosition of previous notification (if applicable)\n\n\n5.017815\n\n\n0.000000\n\n\n5.017815\n\n\n\n\n\n\n\n\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n\n\n8A. Voting rights attached to shares\n\n\n\n\n\n\nClass/Type of shares ISIN code(if possible)\n\n\nNumber of direct voting rights (DTR5.1)\n\n\nNumber of indirect voting rights (DTR5.2.1)\n\n\n% of direct voting rights (DTR5.1)\n\n\n% of indirect voting rights (DTR5.2.1)\n\n\n\n\nGB0009895292 Common Stock\n\n\n\n\n\n66767749\n\n\n\n\n\n4.305580\n\n\n\n\nUS0463531089 Depository Receipt\n\n\n\n\n\n10357599\n\n\n\n\n\n0.667919\n\n\n\n\nSub Total 8.A\n\n\n77125348\n\n\n4.973499%\n\n\n\n\n\n\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\n\n\n\n\n\n\nType of financial instrument\n\n\nExpiration date\n\n\nExercise/conversion period\n\n\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n\n\n% of voting rights\n\n\n\n\n&...